- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 16, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
On Wednesday, the Accountable Care SmartBrief e-newsletter selected an article published in The American Journal of Accountable Care® for its Accountable Care Spotlight roundup. “Evolving Health Workforce Roles in Accountable Care Organizations” used interviews with clinical employees to characterize trends in health workforce roles, such as hiring new workers or expanding current workers’ roles. The researchers learned that most of the practices had focused their workplace transformation efforts on managing care for high-risk, high-cost patients.
Coverage by The American Journal of Managed Care® of the America’s Health Insurance Plans’ Institute & Expo was highlighted in the National Pharmaceutical Council’s daily e-newsletter on June 9. The article, “Embracing Value-Based Contracts for a Sustainable Healthcare System,” described a session that brought together executives from a health plan and an insurer to discuss new payment models. The speakers agreed that value-based agreements can be difficult to develop, but they represent a useful solution to encourage innovation.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
